Predictive Biosciences Starts Prospective Studies for Bladder Cancer Assay

Following a successful pilot study, the company has started two prospective studies to compare how its assay performs against cystoscopy and whether it can more accurately diagnose patients who don't have bladder cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.